WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,20 ฿
0,00%
(0,00) 1D
15 tet, 4:40:00 m.d., GMT+7 · THB
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për WUXI06...
Hap
5,25 ฿
I lartë
5,35 ฿
I ulët
5,05 ฿
Kapitalizimi i tregut
198,43Â mld
Vëllimi mesatar
93,60 mijë
Vëllimi
288,50 mijë
Maksimumi 52-javor
6,25 ฿
Minimumi 52-javor
3,02 ฿
Aksionet në qarkullim
4,12Â mld
Numri i punonjësve
15 mijë
Hap
5,25 ฿
I lartë
5,35 ฿
I ulët
5,05 ฿
Kapitalizimi i tregut
198,43Â mld
Vëllimi mesatar
93,60 mijë
Vëllimi
288,50 mijë
Maksimumi 52-javor
6,25 ฿
Minimumi 52-javor
3,02 ฿
Aksionet në qarkullim
4,12Â mld
Numri i punonjësve
15 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
The Globe and Mail
·
46 minuta më parë
TNL Mediagene Regains Compliance with Nasdaq Minimum Bid Price Requirement
CNBC
·
40 minuta më parë
S&P 500 futures are little changed as index heads for losing week
Yahoo Finance
·
30 minuta më parë
What Invesco NASDAQ 100 ETF (QQQM) Bought: NVIDIA Leads on Oct. 14
Seeking Alpha
·
50 minuta më parë
Dow Jones Bullish Catch-Up Over Nasdaq 100 As AI Rotation Accelerates
Profili
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Rreth Wuxi Biologics (Cayman) Inc. KKPS DR
Drejtori ekzekutivZhisheng Chen
Punonjësit14,7 mijë
Themeluar më2010
Selia-
SektoriHealth care
Uebsajtiwuxibiologics.com